GLYC

GlycoMimetics, Inc.

3.00 USD
-0.01 (-0.33%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

GlycoMimetics, Inc. stock is up 1.69% since 30 days ago. The next earnings date is Mar 27, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 36.36% of the previous 10 March’s closed higher than February. In the last 4 Unusual Options Trades, there were 1 CALL, 3 PUTs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
11 Jan 15:24 21 Jun, 2024 2.50 CALL 190 2435
26 Jan 14:48 20 Sep, 2024 2.50 PUT 300 20
02 Feb 14:56 20 Sep, 2024 2.50 PUT 500 982
21 Feb 17:43 20 Sep, 2024 2.50 PUT 265 1518

About GlycoMimetics, Inc.

GlycoMimetics, Inc. focuses on the discovery and development of novel glycomimetic drugs. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML), as well as in phase 3 trial to treat relapsed/refractory AML.